FDA Inspection 934610 — Celgene Corporation
The FDA completed an inspection of Celgene Corporation on Aug 4, 2015 in Berkeley Heights, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 4, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berkeley Heights, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)